A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

The core symptoms of autism spectrum disorder (ASD) include impaired social communication, repetitive behaviors, and restricted interests. No effective pharmacotherapy for these core deficits exists. Within the domain of social communication, the vasopressin system is implicated in social cognition...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuropsychopharmacology
Glavni autori: Umbricht, Daniel, del Valle Rubido, Marta, Hollander, Eric, McCracken, James T, Shic, Frederick, Scahill, Lawrence, Noeldeke, Jana, Boak, Lauren, Khwaja, Omar, Squassante, Lisa, Grundschober, Christophe, Kletzl, Heidemarie, Fontoura, Paulo
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520775/
https://ncbi.nlm.nih.gov/pubmed/27711048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2016.232
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items